lobbying_activities: 1697000
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1697000 | d95b5879-0f17-4a51-a4c7-9d9d17fee602 | Q2 | RED+BLUE STRATEGIES | 400693064 | HOSPIRA | 2015 | second_quarter | PHA | Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2015-07-15T15:03:39.887000-04:00 |